PMED Stock Overview
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
PEPTONIC medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.06 |
| 52 Week High | SEK 0.13 |
| 52 Week Low | SEK 0.05 |
| Beta | 0.18 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -27.71% |
| 3 Year Change | -95.15% |
| 5 Year Change | -92.95% |
| Change since IPO | -99.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMED | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | 2.6% |
| 1Y | -27.7% | 10.8% | 13.5% |
Return vs Industry: PMED underperformed the Swedish Pharmaceuticals industry which returned 54% over the past year.
Return vs Market: PMED underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
| PMED volatility | |
|---|---|
| PMED Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 12.0% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: PMED has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PMED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 32 | Erik Sundquist | www.peptonicmedical.se |
PEPTONIC medical AB (publ), a pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health. It offers VagiVital, a hormone-free treatment for symptoms related to vaginal atrophy, such as pain during intercourse, burning, itching, and dryness, as well as moisturizing and an oil-based intimate wash. The company also provides lifestyle consumer products under the Lunette brand.
PEPTONIC medical AB (publ) Fundamentals Summary
| PMED fundamental statistics | |
|---|---|
| Market cap | SEK 92.09m |
| Earnings (TTM) | -SEK 31.00m |
| Revenue (TTM) | SEK 40.52m |
2.3x
P/S Ratio-3.0x
P/E RatioIs PMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMED income statement (TTM) | |
|---|---|
| Revenue | SEK 40.52m |
| Cost of Revenue | SEK 20.53m |
| Gross Profit | SEK 20.00m |
| Other Expenses | SEK 51.00m |
| Earnings | -SEK 31.00m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 49.35% |
| Net Profit Margin | -76.50% |
| Debt/Equity Ratio | 6.7% |
How did PMED perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/29 16:04 |
| End of Day Share Price | 2024/01/31 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PEPTONIC medical AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Markus Augustsson | Carlsquare AB |
| Joanna Boquist | Redeye |